Fundraising Fox
Vail Scientific
Minneapolis, US · 2 known investors
Find your way into Vail Scientific
Sign up to see every warm intro you have to Vail Scientific
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vail Scientific team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage. The company serves healthcare providers with medical technology aimed at earlier sepsis diagnosis.
Founders & leadership
TW
Thomas W. BurkeExecutiveExecutive Officer at Vail Scientific, which provides medical and scientific communications services including publication planning, medical writing, and health economics and outcomes research to pharmaceutical, biotech, and nonprofit organizations.
TB
Tom BurkeCEOTom Burke previously held leadership roles in pharmaceutical operations, business development, and P&L management across branded and generic product lines. He brings experience in mergers and acquisitions, manufacturing, supply chain, and corporate strategy.
JW
Josh WaldmanNamed on SEC filing
RL
Russell L MorrisNamed on SEC filing
Board
CA
Carter AndersonBoard director
MN
CC
Curtis CarlsonBoard director
JR
Investors · 2
Reported raises · per SEC filings
Form D private placements$8.1M disclosed across 3 of 4 rounds · 2021–2025
▶$7MraisedMar 2025 · 13 investors · BiotechnologyRule 506(b)
▶$7MraisedMar 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carter R AndersonDirector
- Thomas W. BurkeExecutive Officer
- Clayton J AndersonExecutive Officer, Director
- Michael NathanDirector
- Curtis CarlsonDirector
- Joshua RobinsonDirector
- Offering amount
- $7M
- Amount sold
- $7M
- Placement agents
- The Oak Ridge Financial Services Group, Inc.
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedDec 2023 · 2 investors · BiotechnologyRule 506(b)
▶$400KraisedDec 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael NathanDirector
- Clayton J AndersonExecutive Officer, Director
- Carter AndersonDirector
- Curtis R CarlsonDirector
- Russell MorrisDirector
- Thomas BurkeExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $400K
- First sale
- Nov 2023
- Incorporated
- Limited Liability Company, Minnesota, 2019
- Federal exemptions
- 06b
▶$680KraisedAug 2021 · 8 investors · BiotechnologyRule 506(b)
▶$680KraisedAug 2021 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carter R AndersonDirector
- Tom BurkeExecutive Officer, Director
- Michael NathanDirector
- Josh WaldmanDirector
- Russell L MorrisDirector
- Clayton J AndersonExecutive Officer, Director
- Offering amount
- $937.5K
- Amount sold
- $680K
- First sale
- Jul 2021
- Incorporated
- Limited Liability Company, Minnesota
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Vail Scientific do?
- Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage. The company serves healthcare providers with medical technology aimed at earlier sepsis diagnosis.
- Who are Vail Scientific's investors?
- Vail Scientific's investors include Exit 156 Capital, Sagatagan.
- How much funding has Vail Scientific raised?
- Vail Scientific has disclosed $8.1M raised across 3 of its 4 known rounds.
- Where is Vail Scientific headquartered?
- Vail Scientific is headquartered in Minneapolis, US.